Therapeutic Radiopharmaceuticals Labelled with Copper-67, Rhenium-186 and Scandium-47
Seiten
2021
IAEA (Verlag)
978-92-0-127222-5 (ISBN)
IAEA (Verlag)
978-92-0-127222-5 (ISBN)
- Titel z.Zt. nicht lieferbar
- Portofrei ab CHF 40
- Auch auf Rechnung
- Artikel merken
Presents the outcome of an IAEA coordinated research project (CRP) focusing on the production quality control and radiopharmaceutical aspects of three key radionuclides - 67CU 186Re and 47Sc - which have been selected based on their theranostic potential and their dual production routes.
Theranostic radiopharmaceuticals have shown tremendous capabilities in the last decade in the treatment and diagnosis of human diseases via nuclear medicine procedures. In particular, the use of radiometals has experienced a great increase as a result of the development of relevant production technologies. This publication presents the outcome of an IAEA coordinated research project (CRP) focusing on the production, quality control and radiopharmaceutical aspects of three key radionuclides, 67CU, 186Re and 47Sc, which have been selected based on their theranostic potential and their dual production routes. The publication was compiled using inputs from experts in the field as well as presenting the overall results of the CRP. It contains separate sections for each radionuclide including: nuclear data and information on targetry, irradiation, chemical separation, quality control as well as sample radiopharmaceutical production. The findings and considerations will be of use to scientists and technologists interested in translating research reactor and cyclotron based radioisotope production into practice, as well as to post graduate students in the field.
Theranostic radiopharmaceuticals have shown tremendous capabilities in the last decade in the treatment and diagnosis of human diseases via nuclear medicine procedures. In particular, the use of radiometals has experienced a great increase as a result of the development of relevant production technologies. This publication presents the outcome of an IAEA coordinated research project (CRP) focusing on the production, quality control and radiopharmaceutical aspects of three key radionuclides, 67CU, 186Re and 47Sc, which have been selected based on their theranostic potential and their dual production routes. The publication was compiled using inputs from experts in the field as well as presenting the overall results of the CRP. It contains separate sections for each radionuclide including: nuclear data and information on targetry, irradiation, chemical separation, quality control as well as sample radiopharmaceutical production. The findings and considerations will be of use to scientists and technologists interested in translating research reactor and cyclotron based radioisotope production into practice, as well as to post graduate students in the field.
| Erscheinungsdatum | 01.07.2022 |
|---|---|
| Reihe/Serie | IAEA TECDOC Series |
| Zusatzinfo | 22 illustrations |
| Verlagsort | Vienna |
| Sprache | englisch |
| Maße | 210 x 297 mm |
| Gewicht | 170 g |
| Themenwelt | Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren ► Nuklearmedizin |
| Naturwissenschaften ► Chemie ► Physikalische Chemie | |
| ISBN-10 | 92-0-127222-7 / 9201272227 |
| ISBN-13 | 978-92-0-127222-5 / 9789201272225 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2022)
Lehmanns Media (Verlag)
CHF 55,90
Lehrbuch für Breast Care Nurses und Fachpersonen in der Onkologie
Buch | Hardcover (2020)
Hogrefe (Verlag)
CHF 63,00
